WETS
ABBV icon

Wealth Enhancement Trust Services’s AbbVie ABBV Stock Holding History

Wealth Enhancement Trust Services’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.44M Buy
9,681
+265
+3% +$57K 0.27% 82
2026
Q1 		$2.05M Buy
9,416
+1,791
+23% +$397K 0.25% 85
2025
Q4 		$1.74M Buy
+7,625
New +$1.74M 0.22% 87

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wealth Enhancement Trust Services's ABBV Position: Q2 2026 in Review

Wealth Enhancement Trust Services increased its AbbVie (ABBV) stake by 2.8% in Q2 2026, buying an estimated $57K and bringing the position to 9,681 shares worth $2.44M. The position accounts for 0.27% of the portfolio, ranked #82.

Wealth Enhancement Trust Services first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 3,435 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Wealth Enhancement Trust Services held 9,681 shares of AbbVie worth $2.44M as of Q2 2026.
  • Wealth Enhancement Trust Services bought 265 AbbVie shares in Q2 2026, an estimated $57K.
  • AbbVie made up 0.27% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #82 holding.
  • Wealth Enhancement Trust Services first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 3,435 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.